Velo3D Announces First Quarter 2022 Financial Results
Velo3D, Inc. (NYSE: VLD) reported Q1 2022 revenue of $12.2 million, a 17% sequential increase and over 900% year-over-year. The company's backlog reached a record $55 million, reflecting an 80% increase YoY. Velo3D maintains its FY2022 revenue guidance of $89 million, with over 75% of this amount already recognized or booked. The company initiated volume production of its Sapphire XC system and ended the quarter with $186 million in cash. Despite increasing operating expenses, the company expressed confidence in growth and market expansion plans, particularly in Europe.
- Q1 2022 revenue increased 17% sequentially and >900% YoY.
- Record backlog of $55 million, up >80% YoY.
- Maintained FY2022 revenue guidance of $89 million.
- Initiated volume production of Sapphire XC system.
- Exited Q1 2022 with $186 million in cash.
- GAAP net loss of $65.3 million in Q1 2022.
- Gross margin at 0%, affected by launch customer pricing.
- Operating expenses increased to $28.2 million.
Reiterates FY2022 Revenue Guidance of
-
Record revenue –
17% sequential increase, >900% YoY -
Increasing demand reflected in record total backlog – up >
80% YoY to$55 million -
2022 confidence – Q122 revenue / backlog account for >
75% of 2022 revenue guidance - Manufacturing execution – initiated volume production of Sapphire XC during quarter
-
Maintained strong balance sheet – exited Q122 with
in cash$186 million
“Strong execution enabled us to post our third straight quarter of revenue growth as a public company, add to our backlog and expand our new customer footprint,” said
“We are continuing to cement ourselves as a differentiated technology leader in high value manufacturing. Our metal additive manufacturing technology changes the way products in Aerospace, Energy, Power and other industrial segments are designed and produced. It is used to make some of the most critical parts in these products and we are maintaining our focus on driving the vast blue ocean market opportunity we see before us. This success is reflected in our first quarter results as our customers are using our differentiated technology to design and build the high value metal parts they need to succeed-without compromise,” continued Buller.
“Looking forward, given our first quarter execution, continued bookings growth, revenue visibility through our backlog and the successful ramp of our Sapphire XC production, we are increasingly confident in our ability to meet our 2022 revenue guidance of
($ Millions, except percentages and per-share data) | 1st Quarter 2022 |
4th Quarter 2021 |
1st Quarter 2021 |
GAAP revenue |
|
|
|
GAAP gross margin |
|
|
- |
GAAP net loss1 |
( |
( |
( |
GAAP net loss per diluted share |
( |
( |
( |
|
|
|
|
Non-GAAP net loss2 |
( |
( |
( |
Non-GAAP net loss per diluted share2 |
( |
( |
( |
Cash and Investments |
|
|
|
Information about Velo3D’s use of non-GAAP information, including a reconciliation to
-
Reconciliations to
U.S. generally accepted accounting principles (GAAP) financial measures are presented below under “Non-GAAP Financial Information”. - Non-GAAP net loss and non-GAAP net loss per diluted share exclude stock-based compensation expense, and fair value adjustments for the Company’s warrants and earnout liabilities.
Summary of First Quarter 2022 results
Revenue for the first quarter was
Gross margin for the quarter was
Operating expenses for the quarter rose sequentially to
Net loss for the quarter was
The Company ended the quarter with a strong balance sheet with
Guidance
For fiscal year 2022, given its strong first quarter results and increasing backlog, the Company’s previous guidance remains unchanged.
-
Revenue -
$89 million - Total bookings – 47-49
- Total shipments – 47-49
- Sapphire XC shipments – 23-25
- New customer additions – 23-25
The Company will host a conference call for investors this afternoon to discuss its first quarter 2022 performance at
About
VELO,
Amounts herein pertaining to
Forward-Looking Statements:
This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1996. The Company’s actual results may differ from its expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect”, “estimate”, “project”, “budget”, “forecast”, “anticipate”, “intend”, “plan”, “may”, “will”, “could”, “should”, “believes”, “predicts”, “potential”, “continue”, and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company’s guidance for full year 2022 (including the Company’s estimates for revenue, total Sapphire bookings, total Sapphire shipments, Sapphire XC shipments and new customer additions), the Company’s expectations regarding its pricing, improved production efficiencies and gross margin during 2022, the Company’s strategic priorities for 2022 (including the Company’s market and customer expansion plans), the Company’s expectations regarding its liquidity and capital requirements, and the Company’s other expectations, hopes, beliefs, intentions or strategies for the future. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. You should carefully consider the risks and uncertainties described in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the fiscal year ended
Non-GAAP Financial Information
The Company uses non-GAAP financial measures to help it make strategic decisions, establish budgets and operational goals for managing its business, analyze its financial results and evaluate its performance. The Company also believes that the presentation of these non-GAAP financial measures in this release provides an additional tool for investors to use in comparing the Company’s core business and results of operations over multiple periods. However, the non-GAAP financial measures presented in this release may not be comparable to similarly titled measures reported by other companies due to differences in the way that these measures are calculated. The non-GAAP financial measures presented in this release should not be considered as the sole measure of the Company’s performance and should not be considered in isolation from, or as a substitute for, comparable financial measures calculated in accordance with generally accepted accounting principles accepted in
The information in the table below sets forth the non-GAAP financial measures that the Company uses in this release. Because of the limitations associated with these non-GAAP financial measures, “Non-GAAP Net Loss”, “EBITDA”, “Adjusted EBITDA”, and “Adjusted Operating Expenses”, should not be considered in isolation or as a substitute for performance measures calculated in accordance with GAAP. The Company compensates for these limitations by relying primarily on its GAAP results and using Non-GAAP Net Loss, EBITDA, Adjusted EBITDA, and Adjusted Operating Expenses on a supplemental basis. You should review the reconciliation of the non-GAAP financial measures below and not rely on any single financial measure to evaluate the Company's business.
The following tables reconcile Net loss to Non-GAAP Net Loss, EBITDA, and Adjusted EBITDA and Total Operating Expenses to Adjusted Operating Expenses during the three months ended
NON-GAAP Net Loss Reconciliation | |||||||||||
(Unaudited) | |||||||||||
Three months ended | |||||||||||
(In thousands, except for percentages) | |||||||||||
Revenue | $ |
12,218 |
|
$ |
10,410 |
|
$ |
1,172 |
|
||
Gross Profit |
|
15 |
|
|
1,690 |
|
|
(390 |
) |
||
Net Loss | $ |
(65,341 |
) |
$ |
(14,428 |
) |
$ |
(13,548 |
) |
||
Stock-based compensation |
|
4,957 |
|
|
2,617 |
|
|
315 |
|
||
Loss on fair value of warrants |
|
6,014 |
|
|
1,569 |
|
|
1,514 |
|
||
Loss/(gain) in fair value of contingent earnout liabilities |
|
31,232 |
|
|
(7,261 |
) |
|
- |
|
||
Non-GAAP Net Loss | $ |
(23,138 |
) |
$ |
(17,503 |
) |
$ |
(11,719 |
) |
||
Non-GAAP Net loss per share attributable to common stockholders, basic and diluted | $ |
(0.13 |
) |
$ |
(0.10 |
) |
$ |
(0.73 |
) |
||
Weighted-average shares used in computing Non-GAAP net loss per share attributable to common stockholders, basic and diluted |
|
183,498,082 |
|
|
183,177,088 |
|
|
16,019,559 |
|
||
NON-GAAP Adjusted EBITDA Reconciliation | |||||||||||
(Unaudited) | |||||||||||
Three months ended | |||||||||||
(In thousands, except for percentages) | |||||||||||
Revenue | $ |
12,218 |
|
$ |
10,410 |
|
$ |
1,172 |
|
||
Net Loss |
|
(65,341 |
) |
|
(14,428 |
) |
|
(13,548 |
) |
||
Interest expense |
|
141 |
|
|
1,110 |
|
|
120 |
|
||
Tax expense |
|
- |
|
|
- |
|
|
- |
|
||
Depreciation and amortization |
|
1,019 |
|
|
1,731 |
|
|
365 |
|
||
EBITDA | $ |
(64,181 |
) |
$ |
(11,587 |
) |
$ |
(13,063 |
) |
||
Stock-based compensation |
|
4,957 |
|
|
2,617 |
|
|
315 |
|
||
Loss on fair value of warrants |
|
6,014 |
|
|
1,569 |
|
|
1,514 |
|
||
Loss/(gain) in fair value of contingent earnout liabilities |
|
31,232 |
|
|
(7,261 |
) |
|
- |
|
||
Adjusted EBITDA | $ |
(21,978 |
) |
$ |
(14,662 |
) |
$ |
(11,234 |
) |
||
NON-GAAP Adjusted Operating Expenses Reconciliation | |||||||||||
(Unaudited) | |||||||||||
Three months ended | |||||||||||
(In thousands, except for percentages) | |||||||||||
Revenue | $ |
12,218 |
|
$ |
10,410 |
|
$ |
1,172 |
|
||
Operating expenses | |||||||||||
Research and development |
|
12,915 |
|
|
7,921 |
|
|
4,695 |
|
||
Selling and marketing |
|
5,983 |
|
|
4,657 |
|
|
2,023 |
|
||
General and administrative |
|
9,290 |
|
|
8,190 |
|
|
4,786 |
|
||
Total operating expenses |
|
28,188 |
|
|
20,768 |
|
|
11,504 |
|
||
Stock-based compensation |
|
4,957 |
|
|
2,617 |
|
|
315 |
|
||
Adjusted operating expenses | $ |
23,231 |
|
$ |
18,151 |
|
$ |
11,189 |
|
||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS | |||||||||||
(Unaudited) | |||||||||||
(in thousands, except share and per share data) | |||||||||||
Three months | Three months | Three months | |||||||||
Q1'2022 | Q4'2021 | Q1'2021 | |||||||||
Revenue | |||||||||||
3D Printer | $ |
10,184 |
|
$ |
9,421 |
|
$ |
234 |
|
||
Recurring payment |
|
925 |
|
|
358 |
|
|
263 |
|
||
Support services |
|
1,109 |
|
|
631 |
|
|
675 |
|
||
Total Revenue |
|
12,218 |
|
|
10,410 |
|
|
1,172 |
|
||
Cost of revenue | |||||||||||
3D Printer |
|
10,479 |
|
|
7,386 |
|
|
583 |
|
||
Recurring payment |
|
718 |
|
|
250 |
|
|
187 |
|
||
Support services |
|
1,006 |
|
|
1,084 |
|
|
792 |
|
||
Total cost of revenue |
|
12,203 |
|
|
8,720 |
|
|
1,562 |
|
||
Gross profit |
|
15 |
|
|
1,690 |
|
|
(390 |
) |
||
Operating expenses | |||||||||||
Research and development |
|
12,915 |
|
|
7,921 |
|
|
4,695 |
|
||
Selling and marketing |
|
5,983 |
|
|
4,657 |
|
|
2,023 |
|
||
General and administrative |
|
9,290 |
|
|
8,190 |
|
|
4,786 |
|
||
Total operating expenses |
|
28,188 |
|
|
20,768 |
|
|
11,504 |
|
||
Loss from operations |
|
(28,173 |
) |
|
(19,078 |
) |
|
(11,894 |
) |
||
Interest expense |
|
(141 |
) |
|
(1,110 |
) |
|
(120 |
) |
||
Loss on fair value of warrants |
|
(6,014 |
) |
|
(1,569 |
) |
|
(1,514 |
) |
||
Loss/(gain) in fair value of contingent earnout liabilities |
|
(31,232 |
) |
|
7,261 |
|
|
- |
|
||
Other income (expense), net |
|
219 |
|
|
68 |
|
|
(20 |
) |
||
Loss before provision for income taxes |
|
(65,341 |
) |
|
(14,428 |
) |
|
(13,548 |
) |
||
Provision for income taxes |
|
- |
|
|
- |
|
|
- |
|
||
Net loss and comprehensive loss |
|
(65,341 |
) |
|
(14,428 |
) |
|
(13,548 |
) |
||
Extinguishment of redeemable convertible preferred stock |
|
- |
|
|
- |
|
|
- |
|
||
Net loss attributable to common stockholders | $ |
(65,341 |
) |
$ |
(14,428 |
) |
$ |
(13,548 |
) |
||
Net loss per share attributable to common stockholders, basic and diluted | $ |
(0.36 |
) |
$ |
(0.08 |
) |
$ |
(0.85 |
) |
||
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted |
|
183,498,082 |
|
|
183,177,088 |
|
|
16,019,559 |
|
||
Net loss | $ |
(65,341 |
) |
$ |
(14,428 |
) |
$ |
(13,548 |
) |
||
Net unrealized holding loss on available-for-sale investments |
|
(592 |
) |
|
- |
|
|
- |
|
||
Other comprehensive loss | $ |
(65,933 |
) |
$ |
(14,428 |
) |
$ |
(13,548 |
) |
||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. | |||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||
(Unaudited) | |||||||
(In thousands, except share and per share data) | |||||||
|
|
||||||
|
2022 |
|
|
2021 |
|
||
(in thousands, except share and per share data) | |||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ |
104,426 |
|
$ |
207,602 |
|
|
Short-term investments |
|
81,725 |
|
|
15,483 |
|
|
Accounts receivable, net |
|
10,196 |
|
|
12,778 |
|
|
Inventories |
|
42,820 |
|
|
22,479 |
|
|
Contract assets |
|
1,430 |
|
|
274 |
|
|
Prepaid expenses and other current assets |
|
9,449 |
|
|
9,458 |
|
|
Total current assets |
|
250,046 |
|
|
268,074 |
|
|
Property and equipment, net |
|
12,438 |
|
|
10,046 |
|
|
Equipment on lease, net |
|
9,601 |
|
|
8,366 |
|
|
Other assets |
|
15,389 |
|
|
16,231 |
|
|
Total assets | $ |
287,474 |
|
$ |
302,717 |
|
|
Liabilities and Stockholders' Equity | |||||||
Current liabilities: | |||||||
Accounts payable | $ |
19,609 |
|
$ |
9,882 |
|
|
Accrued expenses and other current liabilities |
|
12,121 |
|
|
9,414 |
|
|
Debt - current portion |
|
5,116 |
|
|
5,114 |
|
|
Contract liabilities |
|
19,386 |
|
|
22,252 |
|
|
Total current liabilities |
|
56,232 |
|
|
46,662 |
|
|
Long-term debt - less current portion |
|
2,422 |
|
|
2,956 |
|
|
Contingent earnout liabilities |
|
142,719 |
|
|
111,487 |
|
|
Warrant liabilities |
|
27,719 |
|
|
21,705 |
|
|
Convertible notes payable |
|
- |
|
|
- |
|
|
Other noncurrent liabilities |
|
8,778 |
|
|
9,492 |
|
|
Total liabilities | $ |
237,870 |
|
$ |
192,302 |
|
|
Commitments and contingencies | |||||||
Stockholders’ equity: | |||||||
Common stock, |
|
2 |
|
|
2 |
|
|
Additional paid-in capital |
|
345,418 |
|
|
340,294 |
|
|
Accumulated other comprehensive income |
|
(608 |
) |
|
(14 |
) |
|
Accumulated deficit |
|
(295,208 |
) |
|
(229,867 |
) |
|
Total stockholders’ equity | $ |
49,604 |
|
$ |
110,415 |
|
|
Total liabilities and stockholders’ equity | |||||||
$ |
287,474 |
|
$ |
302,717 |
|
||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||
(Unaudited) | |||||||||
(In thousands) | |||||||||
Three months ended | |||||||||
Cash flows from operating activities | |||||||||
Net loss |
|
(65,341 |
) |
|
(14,428 |
) |
|
(13,548 |
) |
Adjustments to reconcile net loss to net cash used in operating activities | |||||||||
Depreciation and amortization |
|
1,019 |
|
|
894 |
|
|
363 |
|
Amortization of deferred loan costs |
|
2 |
|
|
837 |
|
|
- |
|
Stock-based compensation |
|
4,957 |
|
|
2,617 |
|
|
315 |
|
Loss on fair value of warrants |
|
6,014 |
|
|
1,569 |
|
|
1,514 |
|
Loss on fair value of contingent earnout liabilities |
|
31,232 |
|
|
(7,261 |
) |
|
- |
|
Changes in assets and liabilities | |||||||||
Accounts receivable |
|
2,582 |
|
|
(6,220 |
) |
|
(4,814 |
) |
Inventories |
|
(16,302 |
) |
|
(4,988 |
) |
|
374 |
|
Contract assets |
|
(1,156 |
) |
|
1,236 |
|
|
2,549 |
|
Prepaid expenses and other current assets |
|
5,036 |
|
|
(5,861 |
) |
|
324 |
|
Other assets |
|
842 |
|
|
(12,092 |
) |
|
20 |
|
Accounts payable |
|
(479 |
) |
|
2,128 |
|
|
2,894 |
|
Accrued expenses and other liabilities |
|
2,707 |
|
|
3,478 |
|
|
979 |
|
Contract liabilities |
|
(2,866 |
) |
|
5,136 |
|
|
6,155 |
|
Other noncurrent liabilities |
|
(713 |
) |
|
7,817 |
|
|
233 |
|
Net cash used in operating activities |
|
(32,466 |
) |
|
(25,138 |
) |
|
(2,642 |
) |
Cash flows from investing activities | |||||||||
Purchase of property and equipment |
|
(1,701 |
) |
|
(8,085 |
) |
|
(120 |
) |
Production of equipment for lease to customers |
|
(1,707 |
) |
|
(1,561 |
) |
|
(3,326 |
) |
Purchases of available-for-sale investments |
|
(66,942 |
) |
|
(15,491 |
) |
|
- |
|
Net cash used in investing activities |
|
(70,350 |
) |
|
(25,137 |
) |
|
(3,446 |
) |
Cash flows from financing activities | |||||||||
Proceeds from Merger, net of transaction costs |
|
- |
|
|
(19,913 |
) |
|
- |
|
Proceeds from loan issuance |
|
- |
|
|
2,400 |
|
|||
Repayment of property and equipment loan |
|
- |
|
|
(20,286 |
) |
|
(992 |
) |
Proceeds from convertible notes |
|
- |
|
|
- |
|
|
5,000 |
|
Repayment of equipment loans |
|
(534 |
) |
|
(533 |
) |
|
- |
|
Issuance of common stock upon exercise of stock options |
|
167 |
|
|
72 |
|
|
39 |
|
Net cash (used in) provided by financing activities |
|
(367 |
) |
|
(40,660 |
) |
|
6,447 |
|
Effect of exchange rate changes on cash and cash equivalents |
|
7 |
|
|
(7 |
) |
|
- |
|
Net change in cash and cash equivalents |
|
(103,176 |
) |
|
(90,942 |
) |
|
359 |
|
Cash and cash equivalents and restricted cash at beginning of period |
|
208,402 |
|
|
299,344 |
|
|
15,517 |
|
Cash and cash equivalents and restricted cash at end of period | $ |
105,226 |
|
$ |
208,402 |
|
$ |
15,876 |
|
Supplemental disclosure of cash flow information | |||||||||
Cash paid for interest | $ |
86 |
|
$ |
560 |
|
$ |
120 |
|
Issuance of common stock warrants in connection with financing | $ |
- |
|
$ |
- |
|
$ |
68 |
|
Unpaid liabilities related to property and equipment | $ |
1,723 |
|
$ |
1,271 |
|
$ |
- |
|
Transfers between inventories and property and equipment | $ |
150 |
|
$ |
- |
|
$ |
- |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20220510005667/en/
Investor Relations:
Bob Okunski, VP Investor Relations
investors@velo3d.com
Media Contact:
dan.sorensen@velo3d.com
Source:
FAQ
What were Velo3D's Q1 2022 revenue results?
What is Velo3D's revenue guidance for FY2022?
How much cash did Velo3D have at the end of Q1 2022?
What is the status of Velo3D's backlog?